Literature DB >> 25982496

Mesenchymal stromal cell-dependent reprogramming of Kupffer cells is mediated by TNF-α and PGE2 and is crucial for liver transplant tolerance.

Yu You1, Jiqin Zhang, Jianping Gong, Yupei Chen, Yue Li, Kang Yang, Zuojin Liu.   

Abstract

The role of mesenchymal stromal cells (MSCs) in the modulation of liver transplant tolerance has attracted significant interest. However, the interaction between MSCs and Kupffer cells (KCs) has received little attention, and the effect of this interaction on liver transplant tolerance remains unclear. KCs were cultured in the presence and absence of MSCs. After 24 h, cells were treated with lipopolysaccharide (LPS), after which the production of cytokines and the expression of surface antigens were measured for cell function identification. Moreover, the effects of the KCs and the prostaglandin E2 (PGE2) levels produced by the MSCs were determined using an experimental rat liver transplantation model. Blood and liver samples were collected at three time points after transplantation for further analysis. After LPS treatment, when compared with the KC single cultures, the expression of pro-inflammatory cytokines (IL-1β, IL-6, MHC-II, CD40, CD80, and CD86) in the coculture system was down-regulated, whereas the expression of anti-inflammatory cytokines (TGF-β, IL-4, PGE2, and IL-10) was markedly increased. These data indicate that MSCs can reprogram the phenotype of KCs. However, KCs treated with miR/TNF-α (tumor necrosis factor) plasmid prior to coculture to inhibit the production of TNF-α resulted in an inhibition of the reprogramming effect of MSCs. Moreover, overexpression of PGE2 in MSCs increased the effect of MSCs on KC reprogramming. After rat liver transplantation, allograft recipients that received MSCs showed better allograft tolerance when compared with rats in which KC function was inhibited. Furthermore, rats treated with MSCs overexpressing PGE2 demonstrated the best liver tolerance of all of the groups tested. MSCs reprogram the phenotype of KCs through TNF-α and PGE2, and this process is crucial for the immunomodulatory function of MSCs in liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25982496     DOI: 10.1007/s12026-015-8660-2

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  24 in total

1.  Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow.

Authors:  Kyung-Ah Cho; Sun-Young Ju; Su Jin Cho; Yun-Jae Jung; So-Youn Woo; Ju-Young Seoh; Ho-Seong Han; Kyung-Ha Ryu
Journal:  Cell Biol Int       Date:  2009-05-08       Impact factor: 3.612

Review 2.  Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review.

Authors:  Jan Voswinkel; Sabine Francois; Jean-Marc Simon; Marc Benderitter; Norbert-Claude Gorin; Mohamad Mohty; Loïc Fouillard; Alain Chapel
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

3.  Glycine blunts transplantative liver ischemia-reperfusion injury by downregulating interleukin 1 receptor associated kinase-4.

Authors:  Zuo-jin Liu; Lu-nan Yan; Shen-wei Li; Hai-bo You; Jian-ping Gong
Journal:  Acta Pharmacol Sin       Date:  2006-11       Impact factor: 6.150

4.  Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.

Authors:  Zhi-Gang Zhao; Wen Xu; Hai-Peng Yu; Bing-Ling Fang; Shu-Hong Wu; Fang Li; Wei-Min Li; Qiu-Bai Li; Zhi-Chao Chen; Ping Zou
Journal:  Cancer Lett       Date:  2011-10-15       Impact factor: 8.679

5.  Kupffer cells influence parenchymal invasion and phenotypic orientation, but not the proliferation, of liver progenitor cells in a murine model of liver injury.

Authors:  Noémi Van Hul; Nicolas Lanthier; Regina Español Suñer; Jorge Abarca Quinones; Nico van Rooijen; Isabelle Leclercq
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

6.  Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells.

Authors:  Beáta Hegyi; Gyöngyi Kudlik; Eva Monostori; Ferenc Uher
Journal:  Biochem Biophys Res Commun       Date:  2012-02-07       Impact factor: 3.575

Review 7.  Role of Kupffer cells in host defense and liver disease.

Authors:  Manfred Bilzer; Frigga Roggel; Alexander L Gerbes
Journal:  Liver Int       Date:  2006-12       Impact factor: 5.828

8.  PGE(2) induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway.

Authors:  Kirsty F MacKenzie; Kristopher Clark; Shaista Naqvi; Victoria A McGuire; Gesa Nöehren; Yosua Kristariyanto; Mirjam van den Bosch; Manikhandan Mudaliar; Pierre C McCarthy; Michael J Pattison; Patrick G A Pedrioli; Geoff J Barton; Rachel Toth; Alan Prescott; J Simon C Arthur
Journal:  J Immunol       Date:  2012-12-14       Impact factor: 5.422

9.  Effect of Kupffer cells on immune tolerance in liver transplantation.

Authors:  Guang-Shun Chen; Hai-Zhi Qi
Journal:  Asian Pac J Trop Med       Date:  2012-12       Impact factor: 1.226

Review 10.  Innate immune cells in liver inflammation.

Authors:  Evaggelia Liaskou; Daisy V Wilson; Ye H Oo
Journal:  Mediators Inflamm       Date:  2012-08-09       Impact factor: 4.711

View more
  9 in total

1.  Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats.

Authors:  Morgan Vandermeulen; Pauline Erpicum; Noella Bletard; Laurence Poma; François Jouret; Olivier Detry
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

2.  Mesenchymal Stromal Cell Therapy in Novel Porcine Model of Diffuse Liver Damage Induced by Repeated Biliary Obstruction.

Authors:  Lucie Vištejnová; Václav Liška; Arvind Kumar; Jana Křečková; Ondřej Vyčítal; Jan Brůha; Jan Beneš; Yaroslav Kolinko; Tereza Blassová; Zbyněk Tonar; Michaela Brychtová; Marie Karlíková; Jaroslav Racek; Hynek Mírka; Petr Hošek; Daniel Lysák; Milena Králíčková
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

3.  Down-Regulated Receptor Interacting Protein 140 Is Involved in Lipopolysaccharide-Preconditioning-Induced Inactivation of Kupffer Cells and Attenuation of Hepatic Ischemia Reperfusion Injury.

Authors:  Guo Yuan; You Yu; Li Ji; Xu Jie; Li Yue; Yang Kang; Gong Jianping; Liu Zuojin
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

4.  MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.

Authors:  Yu You; Jia-Xin Tan; Hai-Su Dai; Hao-Wei Chen; Xue-Jun Xu; Ai-Gang Yang; Yu-Jun Zhang; Lian-Hua Bai; Ping Bie
Journal:  Oncotarget       Date:  2016-08-30

Review 5.  Mesenchymal stromal cells promote liver regeneration through regulation of immune cells.

Authors:  Chenxia Hu; Zhongwen Wu; Lanjuan Li
Journal:  Int J Biol Sci       Date:  2020-01-22       Impact factor: 6.580

6.  Research Status of Mesenchymal Stem Cells in Liver Transplantation.

Authors:  Yu You; Di-Guang Wen; Jian-Ping Gong; Zuo-Jin Liu
Journal:  Cell Transplant       Date:  2019-09-12       Impact factor: 4.064

Review 7.  Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation.

Authors:  Manuel Alfredo Podestà; Giuseppe Remuzzi; Federica Casiraghi
Journal:  Front Immunol       Date:  2021-02-10       Impact factor: 7.561

8.  Tetrandrine identified in a small molecule screen to activate mesenchymal stem cells for enhanced immunomodulation.

Authors:  Zijiang Yang; John Concannon; Kelvin S Ng; Kathleen Seyb; Luke J Mortensen; Sudhir Ranganath; Fangqi Gu; Oren Levy; Zhixiang Tong; Keir Martyn; Weian Zhao; Charles P Lin; Marcie A Glicksman; Jeffrey M Karp
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

Review 9.  Role of prostaglandin E2 in tissue repair and regeneration.

Authors:  Hui Cheng; Haoyan Huang; Zhikun Guo; Ying Chang; Zongjin Li
Journal:  Theranostics       Date:  2021-08-13       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.